Table 3.
Patient characteristic | ESBL-negative n = 98 (%) |
ESBL-positive n = 87 (%) |
P value |
---|---|---|---|
Age | |||
>50 years | 36 (36.7) | 56 (64.4) | ≤0.001 |
≤50 years | 62 (63.3) | 31 (35.6) | |
Sex | |||
Male | 27 (27.6) | 39 (44.8) | 0.05 |
Female | 71 (72.4) | 48 (55.2) | |
Ward | |||
ICU | 15 (33.3) | 23 (28) | ≤0.001 |
Internal medicine | 7 (15.6) | 10 (12.2) | |
Infectious | 5 (11.1) | 14 (17.1) | |
Surgery | 6 (13.3) | 12 (14.6) | |
Gynecology | 4 (8.9) | 7 (8.5) | |
Pediatric | 5 (11.1) | 7 (8.5) | |
Emergency | 1 (2.2) | 6 (7.3) | |
CCU | 2 (4.4) | 3 (3.7) | |
Sample type | 0.001 | ||
Urine | 74 (75.5) | 45 (51.7) | |
CSF | 1 (1) | 1 (1.1) | |
Catheters | 1 (1) | 2 (2.3) | |
Blood | 5 (5.1) | 1 (1.1) | |
Wound | 3 (3.1) | 6 (6.9) | |
Respiratory | 14 (14.3) | 32 (36.8) | |
Drug resistance | |||
Fluoroquinolones resistance | 5 (5.1) | 78 (89.7) | ≤0.001 |
Multidrug resistance | 62 (63.3) | 87 (100.0) |